Chun-Jen Liu, MD, PhD
National Taiwan University Hospital
3
3
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jia-Horng Kao, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Chen-Hua Liu, MD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Nezam Afdhal, MD
Beth Israel Deaconess Medical Center
Shared therapeutic areas:
Eric Bellissant, MD, PhD
Rennes University Hospital
Shared therapeutic areas:
Raymond Chung, MD
Massachusetts General Hospital
Shared therapeutic areas:
Stephen A. Harrison, MD
Brooke Army Medical Center
Shared therapeutic areas:
Marc G Ghany, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Cheng-Chao Liang, MD
Far Eastern Memorial Hospital
Shared therapeutic areas:
Worked with same sponsors:
Shih-Jer Hsu, MD
National Taiwan University Hospital, Yun-Lin Branch
Shared therapeutic areas:
Worked with same sponsors:
Pei-Jer Chen, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients
Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test
All 3 trials loaded